Corporate report

Methiopropamine: a review of the evidence of use and harm

A review of the evidence of use and harm of Methiopropamine (MPA) by the Advisory Council on the Misuse of Drugs (ACMD).

• From: Advisory Council on the Misuse of Drugs
• Published: 16 June 2017

Documents

Methiopropamine (MPA): a review of the evidence of use and harm

PDF, 374 KB, 13 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This ACMD report provides further advice and recommendations about Methiopropamine (MPA).

Published 16 June 2017